HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fine carbohydrate recognition of Euphorbia milii lectin.

Abstract
Glycans are key structures involved in biological processes such as cell attachment, migration, and invasion. Information coded on cell-surface glycans is frequently deciphered by proteins, as lectins, that recognize specific carbohydrate topology. Here, we describe the fine carbohydrate specificity of Euphorbia milii lectin (EML). Competitive assays using various sugars showed that GalNAc was the strongest inhibitor, and that the hydroxyl axial position of C4 and acetamido on C2 of GalNAc are critical points of EML recognition. A hydrophobic locus adjacent to GalNAc is also an important region for EML binding. Direct binding assays of EML revealed a stereochemical requirement for a structure adjacent to terminal GalNAc, showing that GalNAc residue is a necessary but not sufficient condition for EML interaction. The capacity of EML to bind epithelial tumor cells makes it a potentially useful tool for study of some over-expressed GalNAc glycoconjugates.
AuthorsFernando J Irazoqui, Magdolna M Vozari-Hampe, Ricardo D Lardone, Marcos A Villarreal, Victor G Sendra, Guillermo G Montich, Vera M Trindade, Henrik Clausen, Gustavo A Nores
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 336 Issue 1 Pg. 14-21 (Oct 14 2005) ISSN: 0006-291X [Print] United States
PMID16122701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lectins
Topics
  • Carbohydrate Conformation
  • Carbohydrate Metabolism
  • Carbohydrate Sequence
  • Chromatography, Thin Layer
  • Electrophoresis, Polyacrylamide Gel
  • Euphorbia (chemistry)
  • Lectins (metabolism)
  • Models, Molecular
  • Molecular Sequence Data
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: